Assenagon Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $968K | Sell |
|
|||||
|
2025
Q2 | $1.37M | Sell |
|
|||||
|
2025
Q1 | $6.13M | Buy |
|
|||||
|
2024
Q4 | $6.65M | Buy |
|
|||||
|
2024
Q3 | $8.4M | Buy |
|
|||||
|
2024
Q2 | $9.91M | Sell |
|
|||||
|
2024
Q1 | $9.24M | Sell |
|
|||||
|
2023
Q4 | $11.2M | Sell |
|
|||||
|
2023
Q3 | $33.3M | Sell |
|
|||||
|
2023
Q2 | $61.7M | Sell |
|
|||||
|
2023
Q1 | $98.8M | Sell |
|
|||||
|
2022
Q4 | $147M | Sell |
|
|||||
|
2022
Q3 | $161M | Sell |
|
|||||
|
2022
Q2 | $130M | Buy |
|
|||||
|
2022
Q1 | $116M | Buy |
|
|||||
|
2021
Q4 | $83.1M | Sell |
|
|||||
|
2021
Q3 | $213M | Buy |
|
|||||
|
2021
Q2 | $122M | Buy |
|
|||||
|
2021
Q1 | $73.9M | Buy |
|
|||||
|
2020
Q4 | $61.4M | Buy |
|
|||||
|
2020
Q3 | $37.9M | Sell |
|
|||||
|
2020
Q2 | $87.5M | Buy |
|
|||||
|
2020
Q1 | $41.7M | Sell |
|
|||||
|
2019
Q4 | $141M | Sell |
|
|||||
|
2019
Q3 | $157M | Buy |
|
|||||
|
2019
Q2 | $10.9M | Sell |
|
|||||
|
2019
Q1 | $75.7M | Buy |
|
|||||
|
2018
Q4 | $77.9M | Buy |
|
|||||
|
2018
Q3 | $75M | Sell |
|
|||||
|
2018
Q2 | $73.6M | Buy |
|
|||||
|
2018
Q1 | $42.1M | Buy |
|
|||||
|
2017
Q4 | $29.7M | Sell |
|
|||||
|
2017
Q3 | $123M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $23M | Buy |
|